aTYR PHARMA ATYR
NASDAQ ATYR
$0.17 0.00 (-0.58%)
At close: Oct 21, 2026 · 4:00 PM EDT

aTYR PHARMA (ATYR) Non-Current Debt (2014 - 2019)

Updated

aTYR PHARMA (ATYR) posted Non-Current Debt of $4.94 million for Q4 2017.

Analysis

aTYR PHARMA (ATYR) Non-Current Debt (2014 - 2019) Analysis & Trends

For FY2017, aTYR PHARMA's Non-Current Debt came in at $9.87 million, up 1.3% from FY2016.

  • Annual Non-Current Debt shows a three-year compound annual growth rate of 25.4% (FY2014 to FY2017).
  • In prior years, aTYR PHARMA's Non-Current Debt was $9.74 million in FY2016 and $5 million in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 37.34 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 62.48 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 23.68 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 23.83 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 60.50 Bn
10 aTYR PHARMA 16.81 Mn -276.01 Mn - -145,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 2.74 Mn
Jun 30, 2019 4.60 Mn
Mar 31, 2019 6.44 Mn
Dec 31, 2018 8.26 Mn
Sep 30, 2018 10.07 Mn
Jun 30, 2018 11.85 Mn
Mar 31, 2018 12.95 Mn
Dec 31, 2017 14.72 Mn
Sep 30, 2017 12.48 Mn
Jun 30, 2017 11.79 Mn
Mar 31, 2017 8.48 Mn
Dec 31, 2016 9.20 Mn
Mar 31, 2016 896,000.00
Dec 31, 2015 1.78 Mn
Sep 30, 2015 2.64 Mn
Jun 30, 2015 3.49 Mn
Mar 31, 2015 4.32 Mn
Dec 31, 2014 5.14 Mn
API Access

aTYR PHARMA Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=ATYR&period=max&api_key=YOUR_API_KEY